Literature DB >> 27445520

Acute Chest Pain Related to Pericardial Fat Necrosis.

Gilbert R Ferretti1, Dominique Rigaud1.   

Abstract

Entities:  

Mesh:

Year:  2016        PMID: 27445520      PMCID: PMC4904605          DOI: 10.1155/2016/1948325

Source DB:  PubMed          Journal:  Can Respir J        ISSN: 1198-2241            Impact factor:   2.409


× No keyword cloud information.
An otherwise healthy 56-year-old woman (BMI, 31 kg/m2) presented to our emergency department with acute nonradiating left-sided chest pain. She had no associated dyspnea, fever, or other clinical findings. An electrocardiogram and serum troponin level were unremarkable. Nonenhanced computed tomography (CT) of the chest (Figure 1) showed a left anterior low-attenuation (−80 HU) pericardial mass with high attenuation strands measuring 47 mm in diameter, surrounded by an irregular capsule (arrow), and with an associated small pleural effusion (arrowhead). Coronal reformation CT confirmed no connection with infradiaphragmatic tissues (Figure 2). Contrast-enhanced CT (Figure 3) ruled out pulmonary embolism and aortic dissection but confirmed the typical appearance of pericardial fat necrosis. With nonsteroidal anti-inflammatory treatment the pain disappeared. On follow-up CT after 3 months (Figure 4), the mass was still present but significantly reduced in size (28 mm) (arrow).
Figure 1

CT scan without contrast enhancement showing a left anterior low-attenuation (−80 HU) pericardial mass with high attenuation strands surrounded by an irregular capsule (arrow) and a small pleural effusion (arrowhead).

Figure 2

Coronal reformatted CT showing no connection between the pericardial mass and infradiaphragmatic fatty tissues.

Figure 3

Contrast-enhanced CT showing that the central fatty attenuation of the mass is not enhanced (star); the capsule shows a 50 HU increase in density (arrow).

Figure 4

CT scan after 3 months showing a significant reduction in the size of the mass (arrow).

Pericardial (or epipericardial or paracardial) fat necrosis is a rare benign cause of sudden chest pain that can mimic more severe diseases such as myocardial infarction, pulmonary embolism, or pericarditis [1]. Patients with pericardial fat necrosis have no associated systemic symptoms, however, and laboratory tests and echocardiography are unremarkable [1]. Chest radiography may show increased attenuation in a juxtacardiac location and pleural effusion. Computed tomography, the key diagnostic test, shows a mass with fat attenuation located within the anterior mediastinal fat adjacent to the pericardium and surrounded by a ring of increased density that is enhanced after contrast media injection. There is often an associated ipsilateral pleural effusion [2]. It is important to recognize these characteristic CT findings of pericardial fat necrosis to avoid unnecessary exploratory thoracotomy for a benign lesion [3]. James et al. [4] reported a case of mild FDG uptake at PET/CT in a case of pericardial fat necrosis, representing the inflammatory process. The differential diagnosis for a pericardial mass with fat attenuation includes primary fatty tumors (lipoma, liposarcoma, teratoma, and thymolipomas), diaphragmatic hernias with abdominal fat occupying the cardiophrenic space, and mediastinitis.
  4 in total

1.  Epipericardial fat necrosis: radiologic diagnosis and follow-up.

Authors:  Victor Pineda; Jose Cáceres; Jordi Andreu; Jose Vilar; Maria Luisa Domingo
Journal:  AJR Am J Roentgenol       Date:  2005-11       Impact factor: 3.959

2.  A 70-year-old woman with acute chest pain and a paracardiac mass.

Authors:  Fanny Jouan; Karim Sacre; Marie-Pierre Debray; Bruno Crestani; Marie-Paule Chauveheid; Thomas Papo
Journal:  Chest       Date:  2013-03       Impact factor: 9.410

Review 3.  Pericardial fat necrosis.

Authors:  D A Stephens; F Kocab
Journal:  J Thorac Cardiovasc Surg       Date:  1988-04       Impact factor: 5.209

Review 4.  Utility of FDG PET/CT in inflammatory cardiovascular disease.

Authors:  Olga G James; Jared D Christensen; Terence Z Wong; Salvador Borges-Neto; Lynne M Koweek
Journal:  Radiographics       Date:  2011 Sep-Oct       Impact factor: 5.333

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.